Stock Analiz

Chemours Co (CC) financials: revenue, earnings and cash flow

Fiscal 2017–2025 + TTM · from SEC filings · data as of November 13, 2026

Summary

Chemours Co’s revenue went from $6.2B in fiscal 2017 to $5.8B in fiscal 2025, a decline of about 0.8% a year.

Net income in fiscal 2025 was -$386M, a net margin of -6.6%; the best year in this period was 2018 with $995M.

Over the twelve months to September 30, 2026, revenue was $5.8B and net income -$154M.

Free cash flow was $51M in fiscal 2025 and positive in 8 of the 9 years shown.

The diluted share count fell 21% over the period (buybacks).

Revenue, profit and cash flow by year

Revenue
2017: $6.2B172018: $6.6B182019: $5.5B192020: $5.0B202021: $6.3B212022: $6.8B222023: $6.1B232024: $5.8B242025: $5.8B25$5.8B
Net income
2017: $746M172018: $995M182019: -$52M192020: $219M202021: $608M212022: $578M222023: -$253M232024: $69M242025: -$386M25-$386M
Free cash flow
2017: $229M172018: $642M182019: $169M192020: $540M202021: $537M212022: $448M222023: $186M232024: -$993M242025: $51M25$51M
EPS (diluted)
2017: $3.91172018: $5.45182019: $-0.32192020: $1.32202021: $3.60212022: $3.65222023: $-1.70232024: $0.46242025: $-2.5725$-2.57

Income statement

Fiscal yearTTM202520242023202220212020201920182017
Revenue$5.8B$5.8B$5.8B$6.1B$6.8B$6.3B$5.0B$5.5B$6.6B$6.2B
Gross profit$885M$902M$1.1B$1.3B$1.6B$1.4B$1.1B$1.1B$2.0B$1.7B
Operating income$406M-$8M$369M-$110M$904M$861M$389M$84M$1.4B$1.1B
Net income-$154M-$386M$69M-$253M$578M$608M$219M-$52M$995M$746M
EPS (diluted)$-1.02$-2.57$0.46$-1.70$3.65$3.60$1.32$-0.32$5.45$3.91
R&D$104M$108M$109M$108M$118M$107M$93M$80M$82M$81M
Revenue growth—+0.4%−4.9%−11.0%+7.7%+27.7%−10.1%−16.8%+7.4%—

Cash flow

Fiscal yearTTM202520242023202220212020201920182017
Operating cash flow$400M$264M-$633M$556M$755M$814M$807M$650M$1.1B$640M
Capital spending-$189M-$213M-$360M-$370M-$307M-$277M-$267M-$481M-$498M-$411M
Free cash flow$211M$51M-$993M$186M$448M$537M$540M$169M$642M$229M
Dividends paid$54M$78M$148M$149M$154M$164M$164M$164M$148M$22M
Buybacks———$69M$495M$173M$0$322M$644M$106M
Stock-based pay$22M$21M$15M$18M$27M$34M$16M$19M$24M$29M

Balance sheet

Fiscal yearTTM202520242023202220212020201920182017
Cash—$670M$713M$1.2B$1.1B$1.5B$1.1B$943M$1.2B$1.6B
Debt—$4.4B$4.4B$4.3B$3.9B$4.0B$4.3B$4.5B$4.0B$4.2B
Equity—$250M$571M$721M$1.1B$1.1B$813M$689M$1.0B$860M
Total assets—$7.4B$7.5B$8.2B$7.6B$7.5B$7.1B$7.3B$7.4B$7.3B
Shares (diluted)152M150M150M149M158M169M166M165M183M191M

Margins and returns

Fiscal yearTTM202520242023202220212020201920182017
Gross margin15.2%15.5%19.8%21.4%23.7%21.8%21.5%19.2%29.7%28.2%
Operating margin7.0%-0.1%6.4%-1.8%13.2%13.6%7.8%1.5%20.3%18.2%
Net margin-2.6%-6.7%1.2%-4.2%8.5%9.6%4.4%-0.9%15.0%12.1%
FCF margin3.6%0.9%-17.2%3.1%6.6%8.5%10.9%3.1%9.7%3.7%
ROIC—-0.1%4.8%-1.7%14.1%15.2%6.0%1.3%23.1%18.4%
ROE—-154.4%12.1%-35.1%52.2%56.2%26.9%-7.5%98.1%86.7%

Frequently asked questions

What is Chemours Co’s annual revenue?

$5.8B in fiscal 2025 and $5.8B over the twelve months to September 30, 2026.

How much profit does Chemours Co make?

Net income was -$386M in fiscal 2025 (net margin -6.6%).

Is Chemours Co’s revenue growing?

Yes: revenue rose 0.4% in fiscal 2025 compared with the year before.

From the company’s 10-K and 10-Q filings with the SEC; per-share figures adjusted for stock splits. Rebuilt daily. Not investment advice.